A blog exploring pharmaceutical relationship marketing, emarketing and innovation with a focus on rare disorders.
SirenWired
The convergence of rare disease, digital communications, and pharmaceutical marketing communications

#SocPharm Tweetchat Transcript 4/7/2010

Posted by | 9:43pm on Wednesday, April 7, 2010

:
Welcome to pharma marketing & social media #SocPharm chat tonight. Please introduce yourself & say why you are interested in this topic.

:
Frieda Hernandez here. SA Voices is a really interesting case for having a #socpharm strategy #socpharm

:
I work for Siren Interactive & we work with pharma cos with rare disorder therapies. Fascinated by social media. #socpharm

:
@ here. surprised at what appeared to be lack of process (strategic through execution and management) in SA Voices #socpharm

:
Hi Frieda! Plan on talking about @‘s learnings. Did you see @‘s gr8 summary? http://bit.ly/c07Ssz #socpharm

:
One great pt @ made was the more pharma people using SM & creating relationships the better for the companies. #socpharm #socpharm

:
I see an increasing number of pharma employees joining Twitter & using it for themselves, which is wonderful. #socpharm

:
@ @ feel free to check out my summary and observations as wellhttp://bit.ly/cBztdG #socpharm

:
@ Thanks for sharing Steve. #socpharm

:
Incredibly brave (and smart) of @ to be so accessible for discussion #socpharm

:
I apologize for not being very well prepared tonight with questions. Anyone have a question they’d like to discuss? #socpharm

:
Yes! RT @: Plan on talking about @ learnings. Did you see @ gr8 summary? http://bit.ly/c07Ssz #socpharm

:
Tweetchat is running a bit slow tonite #socpharm

:
RT @: 54% of U.S. companies say that they have banned workers from using social networking sites. http://bit.ly/bi0ANO #socpharm

:
@ Agree! As @ said they were hindered by having a quick/easy way to react/communicate. #socpharm

:
@ the more marketers use SM tools the better they will understand how to apply tactically #socpharm

:
@ I also liked Wendy’s point about “collaboration across a number of disciplines and departments.” #socpharm

:
@ It reminds me of back when companies were banning employees from using the Internet at work. So short-sighted! #socpharm

:
T1 Anyone have an opinion on new FDA ad proposals? http://bit.ly/a49DRl #socpharm

:
Many companies confused, lack protocol, & fear loss of control by allowing social network access. Many in charge are unfamiliar #socpharm

:
RT @: RT @: 54% U.S. comp. say they banned workers from using soc. networking sites http://bit.ly/bi0ANO #socpharm

:
agreed RT @: @ I also liked Wendys point abt “collaboration across a number of disciplines and departments.” #socpharm

:
@ Maybe fear can be tempered by improving internal social networking with employees first (Novartis & Yammer.) #socpharm

:
@ Can you expand on how Novartis is using Yammer internally? #socpharm

:
@ great point, most internal communication is one way intranets, which are little used #socpharm

:
Hi #socpharm – shout out from DTC National in DC

:
@ Hi there! Learn anything interesting you’d like to share? #socpharm

:
Does anyone think the new FDA ad proposals are too open to interpretation? #socpharm” target=”_blank”>http://bit.ly/a49DRl#socpharm

:
RT @: Does anyone think the new FDA ad proposals are too open to interpretation?http://bit.ly/a49DRl #socpharm

:
#socpharm Sure – for one, Sir Martin of WPP says he’s seeing strong recovery in Q1

:
@ Well if “Sir Martin” says it…. Seriously, that’s great news and in keeping what we’re seeing. #socpharm

:
RT @: #socpharm Sure – for one, Sir Martin of WPP says hes seeing strong recovery in Q1 #socpharm

:
@ mentioned and ive bn thinking abt is approach SM not as marketing/campaign tool, but as ongoing platform 4 2way convo #socpharm

:
#socpharm DTC audience voted and 66% approve of the healthcare bill.

:
#socpharm to which sir martin said it’s because 30M more people will now get access to meds!

:
RT @: #socpharm DTC audience voted and 66% approve of the healthcare bill. #socpharm

:
@ Absolutely, for one way we have broadcast communications. Social media is completely different. #socpharm

:
@ yes but many on bus/sales side see it as access to many eyeballs, still think in terms of push #socpharm

:
Q2 At eMarketing forum everyone was was talking about true integration of marketing plans. Anyone seeing more of this happening? #socpharm

:
@ agreed, it’s a different mindest to start thinking of creating relationships and lifetime value vs. pushing scripts #socpharm

:
I do see more clients having good offline/online agency + PR collaboration. Customer service still missing piece. #socpharm

:
RT @: @ agreed, it’s a different mindest to start thinking of creating relationships and lifetime value vs. pushing scripts #socpharm

:
RT @: Shocked that s-a Voices FB pg is 2010 Dose of Digital Dosie Awards Finalisthttp://bt.io/EqFh (via @) #socpharm

:
#socpharm a lot of buzz about those 30M people-likely to be less connected, less affuent, lower health literacy

:
@ isnt it more fyi vs. collaboration on integrated planning? #socpharm

:
So? RT @: #socpharm a lot of buzz abt those 30M pple-likely to be less connected, less affuent, lower hlth literacy #socpharm

:
#socpharm fave dtc quote “there will be lots of $ for interventions proven to lower hc costs”

:
@ Good point. Some true integreation, others FYI #socpharm

:
@ R U seeing upfront collaboration,sharing research insights, & jointly planning programs across multiple disciplines? #socpharm

:
Hi guys! Sorry to be late. Now trying to catch up :) #socpharm

:
@ Better late than never…. #socpharm

:
#socpharm @ so .. facebook et al for pharma may hit a stumbling block ..

:
Amen! RT @ @ its diff mindest to start thnkng of creating relationships & lifetime valu vs. pushing scripts #socpharm

:
@ Hello! Isn’t it very late for you, Miguel? #socpharm

:
Q3: Speaking of Facebook I think it’s a BAD idea to change their successful “fan” to “like”. What do u think? http://bit.ly/bsMNZ7 #socpharm

:
@ IMHO I seriously doubt it. Check Pew demo stats. #socpharm

:
#socpharm or, we may want to ff to mobile pharma & skip the web altogether

:
@ I like that: “fast forward” past the web to mobile! #socpharm

:
@ but people are still using their computers at work #socpharm

:
@ Again IMHO all channels have value depending on audience segmentation – 1st step Listen & Learn #socpharm

:
totally agree RT @ Facebook: BAD idea to change successful “fan of” to “like”. What do u think? http://bit.ly/bsMNZ7 #socpharm

:
#socpharm good debate! but, that fluffy hotel bed is calling .. follow #dtc2010 for more tomoro. nite all :)

:
@ Facebook seems to be constantly changing things (and then sometimes changing back). #socpharm

:
@ @ Waiting for the next “Facebook”- Many biz tired of FB, maybe new platform called About Face! :) #socpharm

:
@ Sure, just as pharma starts to get their mind wrapped around Facebook it will be time for the anti-Facebook! #socpharm

:
Did you see this from Ragan.com about FB ? http://bit.ly/9iTpuj #socpharm

:
No, tx for sharing. RT @: Did you see this from Ragan.com about FB ? #socpharm” target=”_blank”>http://bit.ly/9iTpuj#socpharm

:
@ 1 of the reasons @ talked abt creating platforms, if the purpose is relation & listning not mktg, ths works #socpharm

:
I would love to know if FaceBook does actual user testing before these changes #socpharm

:
Just saw a tweet from @: If consumers spend 20% + online… Why are advertisers spending only 10-14%? (Less in pharma) #socpharm

:
@ rationale is less time is spent for older demos, those in the #pharma sweet spot #socpharm

:
@ Sure they don’t, otherwise this wouldn’t happen http://bit.ly/afrnLR #socpharm

:
@ Not so much anymore… Older adults are online, especially where health is concerned. #socpharm

:
Good read RT @: Did you see this from Ragan.com about FB ? #socpharm” target=”_blank”>http://bit.ly/9iTpuj#socpharm

:
Thanks everyone for joining in tonight. See you next Wed at 8 pm est. And on April 28 @ will be guest moderating. #socpharm

:
@ according to pew 9.3% of 50-65 YO use Social networks #socpharm

:
@ Google is same. Why can they make privacy changes, get the data they want & then say “sorry” ? #socpharm

:
TY Eileen for hosting another interesting #socpharm session.

:
@ But the interactive space is bigger than just social networks. #socpharm

:
@ no debate with that! #socpharm

:
Thanks @ and my SocPharm compadres for another fascinating convo! #socpharm

:
odomlewis: You’re right, Angela! #socpharm

:
Thank you, everyone! @ @ @ @ @ #socpharm

:
RT @: @ according to pew 9.3% of 50-65 YO use Social networks #socpharm

:
@ Facebook is an agile platform chameleon. would rather they pilot new things, in a controlled manner #socpharm

:
@ Enjoyed your post, too! Topic of discussion at #socpharm tonight.

:
@ Thank you so much. I had gr8 stuff to work with obviously. Was sad to barely miss #socpharm, Lks like it was good

About Eileen O'Brien

Eileen has more than 16 years of digital healthcare marketing experience. She is an opinion leader on social media and biopharma, and has been invited to speak at industry conferences and quoted in publications.

View other posts from Eileen

Siren Interactive
  • Siren Interactive
  • Rare Disease Relationship Marketing Experts
  • 626 West Jackson Blvd, Suite 100
  • Chicago, IL 60661
  • 312.204.6700
  • 866.502.6714 (Toll Free)
  • www.sireninteractive.com